Acalabrutinib

Acalabrutinib, sold under the brand name Calquence, is a medication used to treat various types of non-Hodgkin lymphoma, including mantle cell lymphoma (MCL) and chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL).[4] It may be used both in relapsed as well as in treatment-naive settings.[5] Common side effects include headaches, feeling tired, low red blood cells, low platelets, and low white blood cells.[4] It is a second genera... [wikipedia]